Excelsior Biopharma Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 368.748 million compared to TWD 416.897 million a year ago. Operating income was TWD 19.828 million compared to TWD 74.899 million a year ago. Net income was TWD 16.052 million compared to TWD 63.855 million a year ago. Basic earnings per share was TWD 0.34 compared to TWD 1.37 a year ago. Diluted earnings per share was TWD 0.34 compared to TWD 1.36 a year ago.